Regulatory Story
Go to market news section View chart   Print
Company GlaxoSmithKline PLC
TIDM GSK
Headline

Blocklisting Interim Review

Released 09:51 17-May-2013
Number 9941E09

RNS Number : 9941E
GlaxoSmithKline PLC
17 May 2013
 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - Ordinary Shares

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

9,717,201

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

10,000,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

11,294,858

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

8,422,343

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - ADS

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

8,362,078

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

15,000,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

14,701,554

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

8,660,524

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome UK Share Option Scheme

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

5,119,750

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

5,119,750

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome International Share Option Scheme

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

13,267,156

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

13,267,156

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome 1999 Share Option Plan

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

1,040,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,040,000

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

163,606

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

163,606

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

275,420

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

275,420

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

  

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

100,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

100,000

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Savings Related Share Option Scheme

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

3,889,981

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,077,551

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,812,430

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 17 May 2013

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc Sharesave plan 2012

Period of return:

From:

1 November 2012

To:

13 May 2013

Balance of unallotted securities under scheme(s) from previous return:

0

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

5,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

4

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

4,996

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGIGDUGUBBGXR
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Blocklisting Interim Review - RNS